Company / Revenue per Share
Regenerative Medical Technology Group Inc. Revenue per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.41
FY2025
5-year range
$0.13 / $0.41
FY2021-FY2025
Trend
+23.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Revenue per Share has increased for 5 consecutive years, from $0.01 in FY2019 to $0.41 in FY2025.
Based on SEC 10-K filings.
0.41 in FY2025 with a 5-year CAGR of +125.9%.
Improved from $0.19 to $0.41 over the past 2 years.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +47.6%
- 5-Year CAGR
- +125.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- Regenerative Medical Technology Group Inc.'s revenue per share has grown for 3 consecutive years.
- In FY2025, revenue per share increased 23.7% year-over-year.
- Lowest revenue per share in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -19.75 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.41 | +23.7% |
| FY2024 | $0.33 | +69.8% |
| FY2023 | $0.19 | +52.9% |
| FY2022 | $0.13 | - |
| FY2021 | - | - |
| FY2020 | $0.01 | +12.7% |
| FY2019 | $0.01 | -54.1% |
| FY2018 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026